Trevena to Report Second Quarter 2019 Results on August 7, 2019
July 31 2019 - 7:00AM
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical
company focused on the development and commercialization of novel
medicines for patients with Central Nervous System (CNS)
conditions, today announced that it will release its financial
results for the second quarter ended June 30, 2019 before the
market opens on Wednesday, August 7, 2019.
The Company will host a conference call and webcast with the
investment community on Wednesday, August 7th at 8:00 a.m. Eastern
Time featuring remarks by Carrie Bourdow, President and CEO, Mark
Demitrack, SVP and Chief Medical Officer, and Barry Shin, SVP and
Chief Financial Officer.
What: |
Trevena Second
Quarter 2019 Results Conference Call |
Date: |
Wednesday, August 7,
2019 |
Time: |
8:00 a.m. ET |
Live
Call: |
Toll-Free: (855)
465-0180International: (484) 756-4313 |
Webcast: |
investors.trevena.com |
Replay: |
Toll-Free: (855)
859-2056International: (404) 537-3406Conference ID:
3799758(Available approximately one hour after the completion of
the live call until 11:59 p.m. ET on August 14, 2019) |
About TrevenaTrevena, Inc. is a
biopharmaceutical company focused on the development and
commercialization of novel medicines for patients with Central
Nervous System conditions. The Company has four novel and
differentiated investigational drug candidates, including IV
oliceridine for the management of moderate to severe acute pain in
hospitals, TRV250 for the acute treatment of migraine, and TRV734
for maintenance treatment of opioid use disorder. The Company has
also identified TRV045, a novel S1P receptor modulator that may
offer a new, non-opioid approach to managing chronic pain.
For more information, please contact:
Investor Contact:Valter Pinto / Allison
SossKCSA Strategic CommunicationsPhone: 212-896-1254 /
212-896-1267Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and Chief
Business OfficerTrevena, Inc.Phone: 610-354-8840
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Apr 2023 to Apr 2024